Arunjyoti Bio Ventures Ltd. Board Meeting Scheduled to Review Quarterly Un-audited Financial Results
Arunjyoti Bio Ventures Limited has scheduled a meeting of its Board of Directors to review the un-audited financial results and related reports for the quarter ending June 30, 2026. The company announced that the Board Meeting will take place on Thursday, July 9, 2026, at the Registered Office of the Company.The primary focus of the meeting is the review of the financial performance during the specified quarter. According to the agenda, the Board is set to consider the un-audited financial results alongside a Limited Review Report for the period that concluded on June 30, 2026.
In addition to reviewing the quarterly financials and Limited Review Report, the Board Meeting is scheduled to address any other business with the permission of the Chair. This meeting provides shareholders and stakeholders insights into the operational health and financial standing of Arunjyoti Bio Ventures Limited for the recently completed quarter.
Stock Price Movement
Arunjyoti Bio Ventures Ltd shares settled on Friday at ₹5.58, ticking up 1.27% in post-market activity. The stock navigated its intraday range successfully, moving between a low of ₹5.48 and an intra-day high of ₹5.70.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.